TY  - GEN
AU  - Samad,A H
AU  - Ty Willing,T S
AU  - Alberti,K G
AU  - Taylor,R
TI  - Effects of BAYm 1099, new alpha-glucosidase inhibitor, on acute metabolic responses and metabolic control in NIDDM over 1 mo
SN  - 0149-5992
PY  - 1988///0922
KW  - 1-Deoxynojirimycin
KW  - analogs & derivatives
KW  - 3-Hydroxybutyric Acid
KW  - Alanine
KW  - blood
KW  - Blood Glucose
KW  - metabolism
KW  - Clinical Trials as Topic
KW  - Diabetes Mellitus, Type 2
KW  - Eating
KW  - Fatty Acids, Nonesterified
KW  - Female
KW  - Glucosamine
KW  - Glycerol
KW  - Glycoside Hydrolase Inhibitors
KW  - Humans
KW  - Hydroxybutyrates
KW  - Hypoglycemic Agents
KW  - therapeutic use
KW  - Imino Pyranoses
KW  - Insulin
KW  - Lactates
KW  - Male
KW  - Middle Aged
KW  - Pyruvates
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.2337/diacare.11.4.337
ER  -